Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317384301> ?p ?o ?g. }
- W4317384301 endingPage "1508" @default.
- W4317384301 startingPage "1492" @default.
- W4317384301 abstract "NG2 is a structurally unique transmembrane chondroitin sulfate proteoglycan (CSPG). Its role in damaged spinal cord is dual. NG2 is considered one of key inhibitory factors restricting axonal growth following spinal injury. Additionally, we have recently detected its novel function as a blocker of axonal conduction. Some studies, however, indicate the importance of NG2 presence in the formation of synaptic contacts. We hypothesized that the optimal treatment would be neutralization of inhibitory functions of NG2 without its physical removal. Acute intraspinal injections of anti-NG2 monoclonal antibodies reportedly prevented an acute block of axonal conduction by exogenous NG2. For prolonged delivery of NG2 function neutralizing antibody, we have developed a novel gene therapy: adeno-associated vector (AAV) construct expressing recombinant single-chain variable fragment anti-NG2 antibody (AAV-NG2Ab). We examined effects of AAV-NG2Ab alone or in combination with neurotrophin NT-3 in adult female rats with thoracic T10 contusion injuries. A battery of behavioral tests was used to evaluate locomotor function. In vivo single-cell electrophysiology was used to evaluate synaptic transmission. Lower urinary tract function was assessed during the survival period using metabolic chambers. Terminal cystometry, with acquisition of external urethral sphincter activity and bladder pressure, was used to evaluate bladder function. Both the AAV-NG2Ab and AAV-NG2Ab combined with AAV-NT3 treatment groups demonstrated significant improvements in transmission, locomotion, and bladder function compared with the control (AAV-GFP) group. These functional improvements associated with improved remyelination and plasticity of 5-HT fibers. The best results were observed in the group that received combinational AAV-NG2Ab+AAV-NT3 treatment.SIGNIFICANCE STATEMENT We recently demonstrated beneficial, but transient, effects of neutralization of the NG2 proteoglycan using monoclonal antibodies delivered intrathecally via osmotic mini-pumps after spinal cord injury. Currently, we have developed a novel gene therapy tool for prolonged and clinically relevant delivery of a recombinant single-chain variable fragment anti-NG2 antibody: AAV-rh10 serotype expressing scFv-NG2 (AAV-NG2Ab). Here, we examined effects of AAV-NG2Ab combined with transgene delivery of Neurotrophin-3 (AAV-NT3) in adult rats with thoracic contusion injuries. The AAV-NG2Ab and AAV-NG2Ab+AAV-NT3 treatment groups demonstrated significant improvements of locomotor function and lower urinary tract function. Beneficial effects of this novel gene therapy on locomotion and bladder function associated with improved transmission to motoneurons and plasticity of axons in damaged spinal cord." @default.
- W4317384301 created "2023-01-19" @default.
- W4317384301 creator A5005118149 @default.
- W4317384301 creator A5025491740 @default.
- W4317384301 creator A5063200479 @default.
- W4317384301 creator A5068276803 @default.
- W4317384301 creator A5068948467 @default.
- W4317384301 creator A5073243618 @default.
- W4317384301 creator A5073649689 @default.
- W4317384301 creator A5079750346 @default.
- W4317384301 creator A5084017030 @default.
- W4317384301 date "2023-01-18" @default.
- W4317384301 modified "2023-10-18" @default.
- W4317384301 title "AAV Vector Mediated Delivery of NG2 Function Neutralizing Antibody and Neurotrophin NT-3 Improves Synaptic Transmission, Locomotion, and Urinary Tract Function after Spinal Cord Contusion Injury in Adult Rats" @default.
- W4317384301 cites W1546694720 @default.
- W4317384301 cites W1557272041 @default.
- W4317384301 cites W1563372168 @default.
- W4317384301 cites W1580343424 @default.
- W4317384301 cites W1583337372 @default.
- W4317384301 cites W1586855301 @default.
- W4317384301 cites W1658991581 @default.
- W4317384301 cites W1676877312 @default.
- W4317384301 cites W1859477582 @default.
- W4317384301 cites W1866366362 @default.
- W4317384301 cites W1963502032 @default.
- W4317384301 cites W1966538134 @default.
- W4317384301 cites W1967109943 @default.
- W4317384301 cites W1968368558 @default.
- W4317384301 cites W1970350515 @default.
- W4317384301 cites W1970901436 @default.
- W4317384301 cites W1972670391 @default.
- W4317384301 cites W1975724680 @default.
- W4317384301 cites W1982935564 @default.
- W4317384301 cites W1985297297 @default.
- W4317384301 cites W1989481781 @default.
- W4317384301 cites W1990840758 @default.
- W4317384301 cites W1997218140 @default.
- W4317384301 cites W1998297893 @default.
- W4317384301 cites W1999874884 @default.
- W4317384301 cites W2002422337 @default.
- W4317384301 cites W2006184315 @default.
- W4317384301 cites W2009580369 @default.
- W4317384301 cites W2010052418 @default.
- W4317384301 cites W2011844996 @default.
- W4317384301 cites W2014007136 @default.
- W4317384301 cites W2016747407 @default.
- W4317384301 cites W2017304903 @default.
- W4317384301 cites W2020006473 @default.
- W4317384301 cites W2020655188 @default.
- W4317384301 cites W2021518416 @default.
- W4317384301 cites W2023849839 @default.
- W4317384301 cites W2025053467 @default.
- W4317384301 cites W2028717305 @default.
- W4317384301 cites W2032972266 @default.
- W4317384301 cites W2038198950 @default.
- W4317384301 cites W2043059291 @default.
- W4317384301 cites W2051833330 @default.
- W4317384301 cites W2064221380 @default.
- W4317384301 cites W2066340179 @default.
- W4317384301 cites W2069377303 @default.
- W4317384301 cites W2076492394 @default.
- W4317384301 cites W2077918706 @default.
- W4317384301 cites W2081422930 @default.
- W4317384301 cites W2081841141 @default.
- W4317384301 cites W2083495275 @default.
- W4317384301 cites W2090419287 @default.
- W4317384301 cites W2091461464 @default.
- W4317384301 cites W2092310903 @default.
- W4317384301 cites W2092541369 @default.
- W4317384301 cites W2097465856 @default.
- W4317384301 cites W2097530133 @default.
- W4317384301 cites W2099134671 @default.
- W4317384301 cites W2104968232 @default.
- W4317384301 cites W2113225284 @default.
- W4317384301 cites W2115819911 @default.
- W4317384301 cites W2141532154 @default.
- W4317384301 cites W2144137250 @default.
- W4317384301 cites W2144373409 @default.
- W4317384301 cites W2145492711 @default.
- W4317384301 cites W2147196321 @default.
- W4317384301 cites W2147531386 @default.
- W4317384301 cites W2150299334 @default.
- W4317384301 cites W2153802181 @default.
- W4317384301 cites W2159022089 @default.
- W4317384301 cites W2162066460 @default.
- W4317384301 cites W2203815387 @default.
- W4317384301 cites W2313790401 @default.
- W4317384301 cites W2314085309 @default.
- W4317384301 cites W2497117355 @default.
- W4317384301 cites W2610833318 @default.
- W4317384301 cites W2954709072 @default.
- W4317384301 cites W3008198525 @default.
- W4317384301 cites W91126227 @default.
- W4317384301 doi "https://doi.org/10.1523/jneurosci.1276-22.2023" @default.
- W4317384301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36653191" @default.
- W4317384301 hasPublicationYear "2023" @default.
- W4317384301 type Work @default.
- W4317384301 citedByCount "3" @default.